Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Call Transcript August 19, 2025
Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.55 EPS, expectations were $-0.27.
Operator: Good day, everyone, and welcome to the Vivos Therapeutics, Inc. Second Quarter 2025 Conference Call. At this time, participants are in a listen-only mode. A question and answer session will follow management’s remarks. This conference call is being recorded, and a replay of today’s...
